 | • レポートコード：QY20ST-00661 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の漢方薬市場について種類別（シロップ、液体、タブレット、その他）、用途別（オンライン販売、オフライン販売）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・漢方薬市場の概要 ・世界の主要地域別漢方薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の漢方薬市場規模2015-2026：種類別（シロップ、液体、タブレット、その他） ・世界の漢方薬市場規模2015-2026：用途別（オンライン販売、オフライン販売） ・漢方薬の北米市場規模2015-2020 ・漢方薬のヨーロッパ市場規模2015-2020 ・漢方薬の中国市場規模2015-2020 ・漢方薬の日本市場規模2015-2020 ・漢方薬の東南アジア市場規模2015-2020 ・漢方薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・漢方薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・漢方薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Chinese Patent Medicine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Chinese Patent Medicine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Chinese Patent Medicine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Chinese Patent Medicine industry.
Based on our recent survey, we have several different scenarios about the Chinese Patent Medicine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Chinese Patent Medicine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Chinese Patent Medicine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Chinese Patent Medicine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Chinese Patent Medicine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Chinese Patent Medicine market. The report also includes nautical information, where it shows Chinese Patent Medicine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Chinese Patent Medicine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Chinese Patent Medicine market.
Geographical Analysis:
Based on region, the global Chinese Patent Medicine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Chinese Patent Medicine market are
Shanghai Pharmaceutical (Group) Co., Ltd.
China Pharmaceutical Group Corporation
Guangzhou Pharmaceutical Group Co., Ltd.
Tianjin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd
Nanjing Pharmaceutical Industry (Group) Co., Ltd.
North China Pharmaceutical Group Co., Ltd.
Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
Taiji Group Co., Ltd.
Xinhualu Anti-Pharmaceutical Group Co., Ltd.
Nanjing Pharmaceutical Co., Ltd
Chongqing Pharmaceutical Co., Ltd
Hangzhou Huadong Pharmaceutical Group Co., Ltd.
Jiangxi Pharmaceutical Group Corporation
Shijiazhuang Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
Segment by Type
Syrup
Liquid
Tablet
Others
Segment by Application
Online Sales
Offline Sales
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Chinese Patent Medicine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Chinese Patent Medicine market.
• The market share of the global Chinese Patent Medicine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Chinese Patent Medicine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Chinese Patent Medicine market.
1 Chinese Patent Medicine Market Overview
1.1 Chinese Patent Medicine Product Scope
1.2 Chinese Patent Medicine Segment by Type
1.2.1 Global Chinese Patent Medicine Sales by Type (2020-2026)
1.2.2 Syrup
1.2.3 Liquid
1.2.4 Tablet
1.2.5 Others
1.3 Chinese Patent Medicine Segment by Application
1.3.1 Global Chinese Patent Medicine Sales Comparison by Application (2020-2026)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Chinese Patent Medicine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Chinese Patent Medicine Sales Growth Rate (2015-2026)
1.4.2 Global Chinese Patent Medicine Revenue and Growth Rate (2015-2026)
1.4.3 Global Chinese Patent Medicine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Chinese Patent Medicine Industry Impact
1.5.1 How the Covid-19 is Affecting the Chinese Patent Medicine Industry
1.5.1.1 Chinese Patent Medicine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Chinese Patent Medicine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Chinese Patent Medicine Players to Combat Covid-19 Impact
2 Chinese Patent Medicine Estimate and Forecast by Region
2.1 Global Chinese Patent Medicine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Chinese Patent Medicine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Chinese Patent Medicine Sales Market Share by Region (2015-2020)
2.2.2 Global Chinese Patent Medicine Revenue Market Share by Region (2015-2020)
2.3 Global Chinese Patent Medicine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Chinese Patent Medicine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Chinese Patent Medicine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Chinese Patent Medicine Estimates and Projections (2015-2026)
2.4.2 Europe Chinese Patent Medicine Estimates and Projections (2015-2026)
2.4.3 China Chinese Patent Medicine Estimates and Projections (2015-2026)
2.4.4 Japan Chinese Patent Medicine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Chinese Patent Medicine Estimates and Projections (2015-2026)
2.4.6 India Chinese Patent Medicine Estimates and Projections (2015-2026)
3 Global Chinese Patent Medicine Competition Landscape by Players
3.1 Global Top Chinese Patent Medicine Players by Sales (2015-2020)
3.2 Global Top Chinese Patent Medicine Players by Revenue (2015-2020)
3.3 Global Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chinese Patent Medicine as of 2019)
3.4 Global Chinese Patent Medicine Average Price by Company (2015-2020)
3.5 Manufacturers Chinese Patent Medicine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Chinese Patent Medicine Players (Opinion Leaders)
4 Global Chinese Patent Medicine Market Size by Type
4.1 Global Chinese Patent Medicine Historic Market Review by Type (2015-2020)
4.1.1 Global Chinese Patent Medicine Sales Market Share by Type (2015-2020)
4.1.2 Global Chinese Patent Medicine Revenue Market Share by Type (2015-2020)
4.1.3 Global Chinese Patent Medicine Price by Type (2014-2020)
4.2 Global Chinese Patent Medicine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Chinese Patent Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Chinese Patent Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Global Chinese Patent Medicine Price Forecast by Type (2021-2026)
5 Global Chinese Patent Medicine Market Size by Application
5.1 Global Chinese Patent Medicine Historic Market Review by Application (2015-2020)
5.1.1 Global Chinese Patent Medicine Sales Market Share by Application (2015-2020)
5.1.2 Global Chinese Patent Medicine Revenue Market Share by Application (2015-2020)
5.1.3 Global Chinese Patent Medicine Price by Application (2015-2020)
5.2 Global Chinese Patent Medicine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Chinese Patent Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Chinese Patent Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Chinese Patent Medicine Price Forecast by Application (2021-2026)
3 North America Chinese Patent Medicine Market Facts & Figures
3.2 North America Chinese Patent Medicine Sales Market Share by Company (2015-2020)
3.3 North America Chinese Patent Medicine Sales Market Share by Type (2015-2020)
3.4 North America Chinese Patent Medicine Sales Market Share by Application (2015-2020)
4 Europe Chinese Patent Medicine Market Facts & Figures
4.2 Europe Chinese Patent Medicine Sales Market Share by Company (2015-2020)
4.3 Europe Chinese Patent Medicine Sales Market Share by Type (2015-2020)
4.4 Europe Chinese Patent Medicine Sales Market Share by Application (2015-2020)
5 China Chinese Patent Medicine Market Facts & Figures
5.2 China Chinese Patent Medicine Sales Market Share by Company (2015-2020)
5.3 China Chinese Patent Medicine Sales Market Share by Type (2015-2020)
5.4 China Chinese Patent Medicine Sales Market Share by Application (2015-2020)
6 Japan Chinese Patent Medicine Market Facts & Figures
6.2 Japan Chinese Patent Medicine Sales Market Share by Company (2015-2020)
6.3 Japan Chinese Patent Medicine Sales Market Share by Type (2015-2020)
6.4 Japan Chinese Patent Medicine Sales Market Share by Application (2015-2020)
7 Southeast Asia Chinese Patent Medicine Market Facts & Figures
7.2 Southeast Asia Chinese Patent Medicine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Chinese Patent Medicine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Chinese Patent Medicine Sales Market Share by Application (2015-2020)
8 India Chinese Patent Medicine Market Facts & Figures
8.2 India Chinese Patent Medicine Sales Market Share by Company (2015-2020)
8.3 India Chinese Patent Medicine Sales Market Share by Type (2015-2020)
8.4 India Chinese Patent Medicine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Chinese Patent Medicine Business
12.1 Shanghai Pharmaceutical (Group) Co., Ltd.
12.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Corporation Information
12.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Products Offered
12.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development
12.2 China Pharmaceutical Group Corporation
12.2.1 China Pharmaceutical Group Corporation Chinese Patent Medicine Corporation Information
12.2.2 China Pharmaceutical Group Corporation Chinese Patent Medicine Business Overview and Total Revenue
12.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Products Offered
12.2.5 China Pharmaceutical Group Corporation Recent Development
12.3 Guangzhou Pharmaceutical Group Co., Ltd.
12.3.1 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Corporation Information
12.3.2 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.3.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
12.3.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Development
12.4 Tianjin Pharmaceutical Group Co., Ltd.
12.4.1 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Corporation Information
12.4.2 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
12.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Development
12.5 Harbin Pharmaceutical Group Co., Ltd
12.5.1 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Corporation Information
12.5.2 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Business Overview and Total Revenue
12.5.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Products Offered
12.5.5 Harbin Pharmaceutical Group Co., Ltd Recent Development
12.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
12.6.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Corporation Information
12.6.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.6.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Products Offered
12.6.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development
12.7 North China Pharmaceutical Group Co., Ltd.
12.7.1 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Corporation Information
12.7.2 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.7.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
12.7.5 North China Pharmaceutical Group Co., Ltd. Recent Development
12.8 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
12.8.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Corporation Information
12.8.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.8.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
12.8.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development
12.9 Taiji Group Co., Ltd.
12.9.1 Taiji Group Co., Ltd. Chinese Patent Medicine Corporation Information
12.9.2 Taiji Group Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.9.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Taiji Group Co., Ltd. Chinese Patent Medicine Products Offered
12.9.5 Taiji Group Co., Ltd. Recent Development
12.10 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
12.10.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Corporation Information
12.10.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.10.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
12.10.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development
12.11 Nanjing Pharmaceutical Co., Ltd
12.11.1 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Corporation Information
12.11.2 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Business Overview and Total Revenue
12.11.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Products Offered
12.11.5 Nanjing Pharmaceutical Co., Ltd Recent Development
12.12 Chongqing Pharmaceutical Co., Ltd
12.12.1 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Corporation Information
12.12.2 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Business Overview and Total Revenue
12.12.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Products Offered
12.12.5 Chongqing Pharmaceutical Co., Ltd Recent Development
12.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
12.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Corporation Information
12.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
12.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development
12.14 Jiangxi Pharmaceutical Group Corporation
12.14.1 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Corporation Information
12.14.2 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Business Overview and Total Revenue
12.14.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Products Offered
12.14.5 Jiangxi Pharmaceutical Group Corporation Recent Development
12.15 Shijiazhuang Pharmaceutical Group Co., Ltd.
12.15.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Corporation Information
12.15.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.15.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
12.15.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development
12.16 Northeast Pharmaceutical Group Co., Ltd.
12.16.1 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Corporation Information
12.16.2 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Business Overview and Total Revenue
12.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
12.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Development
13 Chinese Patent Medicine Manufacturing Cost Analysis
13.1 Chinese Patent Medicine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Chinese Patent Medicine
13.4 Chinese Patent Medicine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Chinese Patent Medicine Distributors List
14.3 Chinese Patent Medicine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Chinese Patent Medicine Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Chinese Patent Medicine Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Chinese Patent Medicine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Chinese Patent Medicine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Chinese Patent Medicine Players to Combat Covid-19 Impact
Table 8. Global Market Chinese Patent Medicine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Chinese Patent Medicine Sales (K MT) by Region (2015-2020)
Table 10. Global Chinese Patent Medicine Sales Market Share by Region (2015-2020)
Table 11. Global Chinese Patent Medicine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Chinese Patent Medicine Revenue Share by Region (2015-2020)
Table 13. Global Chinese Patent Medicine Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Chinese Patent Medicine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Chinese Patent Medicine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Chinese Patent Medicine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Chinese Patent Medicine (K MT) of Key Companies (2015-2020)
Table 18. Global Chinese Patent Medicine Sales Share by Company (2015-2020)
Table 19. Global Chinese Patent Medicine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Chinese Patent Medicine Revenue Share by Company (2015-2020)
Table 21. Global Chinese Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chinese Patent Medicine as of 2019)
Table 22. Global Chinese Patent Medicine Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Chinese Patent Medicine Manufacturing Sites and Area Served
Table 24. Manufacturers Chinese Patent Medicine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Chinese Patent Medicine Players
Table 27. Global Chinese Patent Medicine Sales (K MT) by Type (2015-2020)
Table 28. Global Chinese Patent Medicine Sales Share by Type (2015-2020)
Table 29. Global Chinese Patent Medicine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Chinese Patent Medicine Price (K MT) by Type (2015-2020)
Table 31. Global Chinese Patent Medicine Sales Share by Type (2021-2026)
Table 32. Global Chinese Patent Medicine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Chinese Patent Medicine Revenue Share by Type (2021-2026)
Table 34. Global Chinese Patent Medicine Price (K MT) by Type (2021-2026)
Table 35. Global Chinese Patent Medicine Sales (K MT) by Application (2015-2020)
Table 36. Global Chinese Patent Medicine Sales Share by Application (2015-2020)
Table 37. Global Chinese Patent Medicine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Chinese Patent Medicine Price (K MT) by Application (2015-2020)
Table 39. Global Chinese Patent Medicine Sales (K MT) by Application (2021-2026)
Table 40. Global Chinese Patent Medicine Sales Share by Application (2021-2026)
Table 41. Global Chinese Patent Medicine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Chinese Patent Medicine Revenue Share by Application (2021-2026)
Table 43. Global Chinese Patent Medicine Price (K MT) by Application (2021-2026)
Table 44. United States Chinese Patent Medicine Sales (K MT) by Company (2015-2020)
Table 45. United States Chinese Patent Medicine Sales Market Share by Company (2015-2020)
Table 46. United States Chinese Patent Medicine Sales (K MT) by Type (2015-2020)
Table 47. United States Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 48. United States Chinese Patent Medicine Sales (K MT) by Application (2015-2020)
Table 49. United States Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 50. Europe Chinese Patent Medicine Sales (K MT) by Company (2015-2020)
Table 51. Europe Chinese Patent Medicine Sales Market Share by Company (2015-2020)
Table 52. Europe Chinese Patent Medicine Sales (K MT) by Type (2015-2020)
Table 53. Europe Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 54. Europe Chinese Patent Medicine Sales (K MT) by Application (2015-2020)
Table 55. Europe Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 56. China Chinese Patent Medicine Sales (K MT) by Company (2015-2020)
Table 57. China Chinese Patent Medicine Sales Market Share by Company (2015-2020)
Table 58. China Chinese Patent Medicine Sales (K MT) by Type (2015-2020)
Table 59. China Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 60. China Chinese Patent Medicine Sales (K MT) by Application (2015-2020)
Table 61. China Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 62. Japan Chinese Patent Medicine Sales (K MT) by Company (2015-2020)
Table 63. Japan Chinese Patent Medicine Sales Market Share by Company (2015-2020)
Table 64. Japan Chinese Patent Medicine Sales (K MT) by Type (2015-2020)
Table 65. Japan Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 66. Japan Chinese Patent Medicine Sales (K MT) by Application (2015-2020)
Table 67. Japan Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Chinese Patent Medicine Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Chinese Patent Medicine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Chinese Patent Medicine Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Chinese Patent Medicine Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 74. India Chinese Patent Medicine Sales (K MT) by Company (2015-2020)
Table 75. India Chinese Patent Medicine Sales Market Share by Company (2015-2020)
Table 76. India Chinese Patent Medicine Sales (K MT) by Type (2015-2020)
Table 77. India Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 78. India Chinese Patent Medicine Sales (K MT) by Application (2015-2020)
Table 79. India Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 80. Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 81. Shanghai Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 82. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product
Table 84. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development
Table 85. China Pharmaceutical Group Corporation Corporation Information
Table 86. China Pharmaceutical Group Corporation Description and Business Overview
Table 87. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. China Pharmaceutical Group Corporation Chinese Patent Medicine Product
Table 89. China Pharmaceutical Group Corporation Recent Development
Table 90. Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
Table 91. Guangzhou Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 92. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 94. Guangzhou Pharmaceutical Group Co., Ltd. Recent Development
Table 95. Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
Table 96. Tianjin Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 97. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 99. Tianjin Pharmaceutical Group Co., Ltd. Recent Development
Table 100. Harbin Pharmaceutical Group Co., Ltd Corporation Information
Table 101. Harbin Pharmaceutical Group Co., Ltd Description and Business Overview
Table 102. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product
Table 104. Harbin Pharmaceutical Group Co., Ltd Recent Development
Table 105. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
Table 106. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Business Overview
Table 107. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product
Table 109. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development
Table 110. North China Pharmaceutical Group Co., Ltd. Corporation Information
Table 111. North China Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 112. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 114. North China Pharmaceutical Group Co., Ltd. Recent Development
Table 115. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
Table 116. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 118. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 119. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development
Table 120. Taiji Group Co., Ltd. Corporation Information
Table 121. Taiji Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Taiji Group Co., Ltd. Description and Business Overview
Table 123. Taiji Group Co., Ltd. Chinese Patent Medicine Product
Table 124. Taiji Group Co., Ltd. Recent Development
Table 125. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
Table 126. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 127. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 129. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development
Table 130. Nanjing Pharmaceutical Co., Ltd Corporation Information
Table 131. Nanjing Pharmaceutical Co., Ltd Description and Business Overview
Table 132. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product
Table 134. Nanjing Pharmaceutical Co., Ltd Recent Development
Table 135. Chongqing Pharmaceutical Co., Ltd Corporation Information
Table 136. Chongqing Pharmaceutical Co., Ltd Description and Business Overview
Table 137. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product
Table 139. Chongqing Pharmaceutical Co., Ltd Recent Development
Table 140. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
Table 141. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 142. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 144. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development
Table 145. Jiangxi Pharmaceutical Group Corporation Corporation Information
Table 146. Jiangxi Pharmaceutical Group Corporation Description and Business Overview
Table 147. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product
Table 149. Jiangxi Pharmaceutical Group Corporation Recent Development
Table 150. Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
Table 151. Shijiazhuang Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 152. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 154. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development
Table . Northeast Pharmaceutical Group Co., Ltd. Corporation Information
Table . Northeast Pharmaceutical Group Co., Ltd. Description and Business Overview
Table . Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table . Northeast Pharmaceutical Group Co., Ltd. Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Chinese Patent Medicine Distributors List
Table 163. Chinese Patent Medicine Customers List
Table 164. Market Key Trends
Table 165. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 166. Key Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Chinese Patent Medicine Product Picture
Figure 2. Global Chinese Patent Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Chinese Patent Medicine Market Share by Application in 2020 & 2026
Figure 6. Online Sales Examples
Figure 7. Offline Sales Examples
Figure 8. Global Chinese Patent Medicine Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Chinese Patent Medicine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Chinese Patent Medicine Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Chinese Patent Medicine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Chinese Patent Medicine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Chinese Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Chinese Patent Medicine Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Chinese Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Chinese Patent Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Chinese Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Chinese Patent Medicine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Chinese Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Chinese Patent Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Chinese Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Chinese Patent Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Chinese Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Chinese Patent Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Chinese Patent Medicine Players Market Share by Revenue in Chinese Patent Medicine 2015 & 2019
Figure 26. Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Chinese Patent Medicine Revenue Share by Type (2015-2020)
Figure 28. Global Chinese Patent Medicine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Chinese Patent Medicine Revenue Share by Application (2015-2020)
Figure 30. Global Chinese Patent Medicine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Chinese Patent Medicine Sales Market Share by Type in 2019
Figure 32. United States Chinese Patent Medicine Sales Market Share by Type in 2019
Figure 33. Europe Chinese Patent Medicine Sales Market Share by Company in 2019
Figure 34. Europe Chinese Patent Medicine Sales Market Share by Type in 2019
Figure 35. Europe Chinese Patent Medicine Sales Market Share by Application in 2019
Figure 36. China Chinese Patent Medicine Sales Market Share by Company in 2019
Figure 37. China Chinese Patent Medicine Sales Market Share by Type in 2019
Figure 38. China Chinese Patent Medicine Sales Market Share by Application in 2019
Figure 39. Japan Chinese Patent Medicine Sales Market Share by Company in 2019
Figure 40. Japan Chinese Patent Medicine Sales Market Share by Type in 2019
Figure 41. Japan Chinese Patent Medicine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Chinese Patent Medicine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Chinese Patent Medicine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Chinese Patent Medicine Sales Market Share by Application in 2019
Figure 45. India Chinese Patent Medicine Sales Market Share by Company in 2019
Figure 46. India Chinese Patent Medicine Sales Market Share by Type in 2019
Figure 47. India Chinese Patent Medicine Sales Market Share by Application in 2019
Figure 48. Shanghai Pharmaceutical (Group) Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. China Pharmaceutical Group Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Guangzhou Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Tianjin Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Harbin Pharmaceutical Group Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. North China Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Taiji Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Nanjing Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Chongqing Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Jiangxi Pharmaceutical Group Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Shijiazhuang Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Northeast Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Chinese Patent Medicine
Figure 66. Manufacturing Process Analysis of Chinese Patent Medicine
Figure 67. Chinese Patent Medicine Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
漢方薬（TCM）抽出の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Extraction of Traditional Chinese Medicine (TCM) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players…- 中国筆の世界市場レポート2020 A recently published report by QY Research titled Global Chinese Brushes Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- 紹興酒の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chinese Rice Wine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chinese Rice Wine market re…
- 中国穀物アルコールの世界市場レポート2020 A recently published report by QY Research titled Global Chinese Grain Alcohol Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accur…
- 21弦ストリングの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Twenty-one Strings Chinese Guzheng market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Twenty-one…